TIRUMOTECAN

Clinical trials for TIRUMOTECAN explained in plain language.

Never miss a new study

Get alerted when new TIRUMOTECAN trials appear

Sign up with your email to follow new studies for TIRUMOTECAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for rare kidney cancer: drug trial targets tough tumors

Disease control Not yet recruiting

This study tests a drug called sacituzumab tirumotecan in 20 people with a rare and aggressive kidney cancer (SMARCB1-deficient renal medullary carcinoma) that has worsened after at least one prior treatment. The goal is to see if the drug can shrink or control the cancer. Resear…

Matched conditions: TIRUMOTECAN

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

TIRUMOTECAN

Get alerted when new TIRUMOTECAN trials appear

New hope for rare kidney cancer: drug trial targets tough tumors